Does MIRTAZAPINE Cause Diffuse large b-cell lymphoma refractory? 5 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Diffuse large b-cell lymphoma refractory have been filed in association with MIRTAZAPINE (Mirtazapine). This represents 0.0% of all adverse event reports for MIRTAZAPINE.
5
Reports of Diffuse large b-cell lymphoma refractory with MIRTAZAPINE
0.0%
of all MIRTAZAPINE reports
3
Deaths
0
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma refractory From MIRTAZAPINE?
Of the 5 reports, 3 (60.0%) resulted in death.
Is Diffuse large b-cell lymphoma refractory Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MIRTAZAPINE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does MIRTAZAPINE Cause?
Toxicity to various agents (2,758)
Drug ineffective (1,874)
Somnolence (1,695)
Completed suicide (1,535)
Fall (1,461)
Intentional overdose (1,458)
Drug abuse (1,408)
Dizziness (1,234)
Fatigue (1,192)
Nausea (1,142)
What Other Drugs Cause Diffuse large b-cell lymphoma refractory?
RITUXIMAB (461)
CYCLOPHOSPHAMIDE (360)
DOXORUBICIN (345)
VINCRISTINE (331)
ETOPOSIDE (244)
PREDNISONE (214)
EPCORITAMAB-BYSP (198)
CYTARABINE (193)
DEXAMETHASONE (170)
CISPLATIN (156)
Which MIRTAZAPINE Alternatives Have Lower Diffuse large b-cell lymphoma refractory Risk?
MIRTAZAPINE vs MIRVASO
MIRTAZAPINE vs MIRVETUXIMAB SORAVTANSINE-GYNX
MIRTAZAPINE vs MISOPROSTOL
MIRTAZAPINE vs MITAPIVAT
MIRTAZAPINE vs MITOMYCIN